繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
立即開戶
牛牛AI助理已提取核心訊息
On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.
On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.
2024年9月6日，總部位於特拉華州的健康公司Safety Shot, Inc.宣佈針對其臨床支持的配方獲得了新的美國專利的許可通知。該專利是該公司投資組合的重要組成部分，將Safety Shot區分爲一家專注於解決與酒精相關問題的新市場類別領導者。首席運營官David Sandler和首席執行官Jarret Boon，專利的共同所有者，強調了該專利在鞏固公司競爭優勢和致力於消費者解決方案方面的作用。Safety Shot的產品支持酒精代謝並減少毒素積累，可在線購買，正在擴展到業務對業務銷售。該公告還包括關於公司計劃和潛在風險的前瞻性聲明，這些聲明在其美國證券交易委員會申報中披露。
2024年9月6日，總部位於特拉華州的健康公司Safety Shot, Inc.宣佈針對其臨床支持的配方獲得了新的美國專利的許可通知。該專利是該公司投資組合的重要組成部分，將Safety Shot區分爲一家專注於解決與酒精相關問題的新市場類別領導者。首席運營官David Sandler和首席執行官Jarret Boon，專利的共同所有者，強調了該專利在鞏固公司競爭優勢和致力於消費者解決方案方面的作用。Safety Shot的產品支持酒精代謝並減少毒素積累，可在線購買，正在擴展到業務對業務銷售。該公告還包括關於公司計劃和潛在風險的前瞻性聲明，這些聲明在其美國證券交易委員會申報中披露。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間